Director/PDMR Shareholding

Hikma Pharmaceuticals Plc

31 May 2023

 

Hikma Pharmaceuticals PLC - LTIP and EIP Awards

LONDON, 31 May 2023: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) (LEI: 549300BNS685UXH4JI75) announces that the Remuneration Committee made the following conditional awards under the Hikma Pharmaceuticals PLC 2023 Long Term Incentive Plan (the "LTIP"); the 2014 Executive Incentive Plan (the "EIP") to Persons Discharging Managerial Responsibility ("PDMR") of the Company. No consideration was paid for the grant of the awards.

Awards under the LTIP were made on 30 May 2023 based on a price of £18.43 per Ordinary Share (being the average mid-market Ordinary Share price for the for the 5-working day period prior to 30 May 2023, in accordance with the LTIP rules) (the "LTIP Awards"). The vesting of the LTIP Awards is subject to the continued employment of the PDMRs, malus and clawback provisions and the satisfaction of performance conditions set by the Remuneration Committee of the Company. The LTIP Awards will normally vest on the later of the third anniversary of the date of grant and the determination of the performance conditions. The LTIP Awards are then subject to an additional two-year holding period.

Awards under the EIP were made on 30 May 2023 based on a price of £15.15 per Ordinary Share (being the average mid-market Ordinary Share price for the 30-day period prior to 31 December 2022, in accordance with the EIP rules) (the "EIP Awards"). All EIP Awards are subject to malus and clawback provisions. EIP Element B Awards will normally vest on the second anniversary of the date of grant, subject to continued employment, and are then subject to an additional three-year holding period. EIP Element C Awards will normally vest on the third anniversary of the date of grant, subject to continued employment, and are then subject to an additional two-year holding period.

This notification is made under Article 19(1) of the EU Market Abuse Regulation 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"). The information set out below is provided in accordance with the requirements of Article 19(3) of MAR.

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Said Darwazah
2	Reason for the notification
a)	Position/status	Executive Chairman and Chief Executive Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Grant of awards under the LTIP and EIP.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	LTIP Award: 132,783 Shares
		Nil	EIP Award, Element B: 31,679 Shares
		Nil	EIP Award, Element C: 19,761 Shares
d)	Aggregated information	Price(s): nil Volume(s): 184,223
e)	Date of the transaction	30 May 2023
f)	Place of the transaction	Outside a trading venue

Mazen Darwazah

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mazen Darwazah
2	Reason for the notification
a)	Position/status	Executive Vice Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Grant of awards under the LTIP and EIP.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	LTIP Award: 105,233 Shares
		Nil	EIP Award, Element B: 36,171 Shares
		Nil	EIP Award, Element C: 20,650 Shares
d)	Aggregated information	Price(s): nil Volume(s): 162,054
e)	Date of the transaction	30 May 2023
f)	Place of the transaction	Outside a trading venue

Bassam Kanaan

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Bassam Kanaan
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Grant of awards under the LTIP and EIP.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	LTIP Award: 76,130 Shares
		Nil	EIP Award, Element B: 28,647 Shares
		Nil	EIP Award, Element C: 20,982 Shares
d)	Aggregated information	Price(s): nil Volume(s): 125,759
e)	Date of the transaction	30 May 2023
f)	Place of the transaction	Outside a trading venue

Khalid Nabilsi

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Khalid Nabilsi
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Grant of awards under the LTIP and EIP.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	LTIP Award: 74,699 Shares
		Nil	EIP Award, Element B: 28,833 Shares
		Nil	EIP Award, Element C: 22,209 Shares
d)	Aggregated information	Price(s): nil Volume(s): 125,741
e)	Date of the transaction	30 May 2023
f)	Place of the transaction	Outside a trading venue

Riad Mishlawi

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Riad Mishlawi
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Grant of awards under the LTIP and EIP.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	LTIP Award: 75,339 Shares
		Nil	EIP Award, Element B: 36,371 Shares
		Nil	EIP Award, Element C: 30,749 Shares
d)	Aggregated information	Price(s): nil Volume(s): 142,459
e)	Date of the transaction	30 May 2023
f)	Place of the transaction	Outside a trading venue

Majda Labadi

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Majda Labadi
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Grant of awards under the LTIP and EIP.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	LTIP Award: 50,301 Shares
		Nil	EIP Award, Element B: 18,836 Shares
		Nil	EIP Award, Element C: 13,796 Shares
d)	Aggregated information	Price(s): nil Volume(s): 82,933
e)	Date of the transaction	30 May 2023
f)	Place of the transaction	Outside a trading venue

Susan Ringdal

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Susan Ringdal
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Grant of awards under the LTIP and EIP.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	LTIP Award: 38,409 Shares
		Nil	EIP Award, Element B: 15,925 Shares
		Nil	EIP Award, Element C: 11,664 Shares
d)	Aggregated information	Price(s): nil Volume(s): 65,998
e)	Date of the transaction	30 May 2023
f)	Place of the transaction	Outside a trading venue

Brian Hoffmann

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Brian Hoffmann
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Grant of awards under the LTIP and EIP.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	LTIP Award: 54,422 Shares
		Nil	EIP Award, Element B: 12,233 Shares
		Nil	EIP Award, Element C: 8,302 Shares
d)	Aggregated information	Price(s): nil Volume(s): 74,957
e)	Date of the transaction	30 May 2023
f)	Place of the transaction	Outside a trading venue

Hussein Arkhagha

1	Details of the person discharging managerial responsibilities / person   closely associated
a)	Name	Hussein Arkhagha
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification   /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares)  ID Code: GB00B0LCW083
b)	Nature of the transaction	Grant of awards under the LTIP and EIP.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	LTIP Award: 41,408 Shares
		Nil	EIP Award, Element B: 15,983 Shares
		Nil	EIP Award, Element C: 12,406 Shares
d)	Aggregated information	Price(s): nil Volume(s): 69,797
e)	Date of the transaction	30 May 2023
f)	Place of the transaction	Outside a trading venue

Helen Middlemist

Deputy Company Secretary
[phone]

 

END